Literature DB >> 12603786

Daytime testing after laboratory or home-based polysomnography: comparisons of middle-aged insomnia sufferers and normal sleepers.

Jack D Edinger1, D Michael Glenn, Lori A Bastian, Gail R Marsh, Dorothy Dailey, T Victor Hope, Margaret Young, Edmund Shaw, George Meeks.   

Abstract

Many studies have shown only modest differences between insomnia sufferers and matched, non-complaining normal controls in regard to their levels of daytime sleepiness and diurnal performances. The current study was conducted to determine whether such daytime comparisons might be affected by the setting (home vs. sleep lab) in which study participants sleep on the nights before such testing. The study used a counter-balanced, matched-group design in which participants underwent three consecutive nocturnal polysomnographs (PSG) conducted either in the sleep lab or in their homes prior to undergoing daytime multiple sleep latency test (MSLT) and computer-administered performance testing. The study participants were 35 (18 women and 17 men) middle-aged (40-59 years) non-complaining normal sleepers and 33 middle-aged insomnia sufferers (17 women and 16 men) who met structured interview criteria for persistent primary insomnia. Use of a hierarchical linear statistical model showed only insomnia sufferers who underwent nocturnal home PSG were more alert on the MSLT than were normal sleepers who underwent lab PSG. However, these insomnia sufferers showed a greater propensity toward attention lapses on selected reaction time tests than did either of the two normal control groups (i.e. either those who slept in the lab or those who slept at home). The results suggest the nocturnal sleep setting (home vs. lab) may affect subsequent MSLT and performance test comparisons of insomnia sufferers and normal sleepers.

Entities:  

Mesh:

Year:  2003        PMID: 12603786     DOI: 10.1046/j.1365-2869.2003.00335.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  11 in total

1.  Fatigue or daytime sleepiness?

Authors:  Ravi Singareddy; Edward O Bixler; Alexandros N Vgontzas
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

Review 2.  Has adult sleep duration declined over the last 50+ years?

Authors:  Shawn D Youngstedt; Eric E Goff; Alexandria M Reynolds; Daniel F Kripke; Michael R Irwin; Richard R Bootzin; Nidha Khan; Girardin Jean-Louis
Journal:  Sleep Med Rev       Date:  2015-08-28       Impact factor: 11.609

3.  Treating primary insomnia: clinical effectiveness and predictors of outcomes on sleep, daytime function and health-related quality of life.

Authors:  L Van Houdenhove; B Buyse; L Gabriëls; O Van den Bergh
Journal:  J Clin Psychol Med Settings       Date:  2011-09

4.  Discrepancy between subjective symptomatology and objective neuropsychological performance in insomnia.

Authors:  Henry J Orff; Sean P A Drummond; Sara Nowakowski; Michael L Perils
Journal:  Sleep       Date:  2007-09       Impact factor: 5.849

5.  Augmenting usual care SSRIs with cognitive behavioral therapy for insomnia to improve depression outcomes in youth: Design of a randomized controlled efficacy-effectiveness trial.

Authors:  Greg Clarke; Christina R Sheppler; Alison J Firemark; Andreea M Rawlings; John F Dickerson; Michael C Leo
Journal:  Contemp Clin Trials       Date:  2020-02-28       Impact factor: 2.226

6.  Age-related reduction in the maximal capacity for sleep--implications for insomnia.

Authors:  Elizabeth B Klerman; Derk-Jan Dijk
Journal:  Curr Biol       Date:  2008-07-24       Impact factor: 10.834

7.  Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.

Authors:  Olivier Andlauer; Hyatt Moore; Laura Jouhier; Christopher Drake; Paul E Peppard; Fang Han; Seung-Chul Hong; Francesca Poli; Giuseppe Plazzi; Ruth O'Hara; Emmanuel Haffen; Thomas Roth; Terry Young; Emmanuel Mignot
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

Review 8.  Orexin receptor antagonists as therapeutic agents for insomnia.

Authors:  Ana C Equihua; Alberto K De La Herrán-Arita; Rene Drucker-Colin
Journal:  Front Pharmacol       Date:  2013-12-25       Impact factor: 5.810

9.  Examination of daytime sleepiness and cognitive performance testing in patients with primary insomnia.

Authors:  Hong Liu; Dexi Wang; Yun Li; Zhe Li; Ying Zhang; Fei Lei; Lina Du; Xiangdong Tang
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

10.  On-the-road driving performance and driving-related skills in older untreated insomnia patients and chronic users of hypnotics.

Authors:  T R M Leufkens; J G Ramaekers; A W de Weerd; W J Riedel; A Vermeeren
Journal:  Psychopharmacology (Berl)       Date:  2014-02-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.